{"title":"Research Catalog","description":null,"products":[{"product_id":"tirzepatide","title":"Tirzepatide (Dual Agonist | GLP-1 \/ GIP | Metabolic Pathway Research)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp class=\"additional-info-sections__item-description\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" data-v-9492fc08=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003eTirzepatide has been studied extensively in human clinical trials as a \u003cstrong\u003edual GIP\/GLP-1 receptor agonist\u003c\/strong\u003e. In approved medical settings, it is used as a once-weekly injectable medication for type 2 diabetes under the brand \u003cstrong\u003eMounjaro\u003c\/strong\u003e, and for chronic weight management under \u003cstrong\u003eZepbound\u003c\/strong\u003e in some countries. Its main research interest comes from its ability to activate two incretin pathways involved in glucose control, appetite signaling, insulin response, gastric emptying, and body-weight regulation.\u003c\/p\u003e\n\u003ch3\u003ePotential benefits observed in human studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSignificant body-weight reduction\u003c\/strong\u003e\u003cbr\u003eIn obesity studies, tirzepatide produced substantial average weight loss compared with placebo. SURMOUNT-1 reported body-weight reductions in the range of about \u003cstrong\u003e16% to 22.5%\u003c\/strong\u003e, depending on dose group.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eImproved glycemic control\u003c\/strong\u003e\u003cbr\u003eIn type 2 diabetes studies, tirzepatide has shown strong reductions in \u003cstrong\u003eHbA1c\u003c\/strong\u003e, fasting glucose, and overall markers of blood-sugar control. SURPASS trial analyses describe consistent reductions in both HbA1c and body weight across studied doses.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eDual-pathway metabolic activity\u003c\/strong\u003e\u003cbr\u003eBecause tirzepatide activates both \u003cstrong\u003eGIP\u003c\/strong\u003e and \u003cstrong\u003eGLP-1\u003c\/strong\u003e receptors, it gives researchers a way to study combined incretin signaling rather than GLP-1 activity alone.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAppetite and satiety pathway effects\u003c\/strong\u003e\u003cbr\u003eHuman studies suggest tirzepatide can influence appetite regulation, food intake behavior, and satiety signaling, which may contribute to weight-related outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePotential cardiometabolic improvements\u003c\/strong\u003e\u003cbr\u003eWeight loss and glycemic improvement may also be associated with improvements in metabolic markers such as waist circumference, blood pressure, insulin sensitivity, and lipid-related parameters, depending on the study population.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOnce-weekly dosing in approved formulations\u003c\/strong\u003e\u003cbr\u003eIts long-acting structure supports once-weekly administration in approved pharmaceutical products, which is one reason it is widely studied in metabolic medicine.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed in human studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGastrointestinal side effects are common\u003c\/strong\u003e\u003cbr\u003eNausea, diarrhea, vomiting, constipation, abdominal discomfort, and decreased appetite are among the most commonly reported effects. These often occur during dose escalation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNot suitable for everyone\u003c\/strong\u003e\u003cbr\u003eFDA labeling lists contraindications for people with a personal or family history of \u003cstrong\u003emedullary thyroid carcinoma\u003c\/strong\u003e or \u003cstrong\u003eMEN 2\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRequires medical supervision when used clinically\u003c\/strong\u003e\u003cbr\u003eIn human use, tirzepatide should only be used as an approved medication prescribed and monitored by a licensed healthcare professional. It is not appropriate to use research-grade or unapproved peptide products in humans.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePotential for dehydration or kidney-related issues\u003c\/strong\u003e\u003cbr\u003eSevere vomiting or diarrhea can increase dehydration risk, which may worsen kidney function in vulnerable patients.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePossible gallbladder and pancreatitis concerns\u003c\/strong\u003e\u003cbr\u003eGLP-1–based therapies are commonly monitored for symptoms related to gallbladder disease and pancreatitis risk.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWeight regain can occur after discontinuation\u003c\/strong\u003e\u003cbr\u003eLike many chronic metabolic treatments, benefits may decrease when therapy stops, especially without sustained lifestyle and medical management.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eHuman clinical data on tirzepatide is promising, especially for metabolic and weight-related outcomes, but human use should only involve approved, regulated medication under licensed medical supervision. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 10mg","offer_id":51939087221024,"sku":null,"price":1700.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 15mg","offer_id":51939087253792,"sku":null,"price":2100.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 30mg","offer_id":51939087286560,"sku":null,"price":2500.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 15mg","offer_id":51939282583840,"sku":null,"price":3800.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 30mg","offer_id":51939282616608,"sku":null,"price":4300.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/7c3c37f9-8903-42ed-90c0-e38d808e2b4a.png?v=1783142957"},{"product_id":"retatrutide","title":"Retatrutide (Triple Agonist | GLP-1 \/ GIP \/ Glucagon | Metabolic Pathway Research)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp class=\"additional-info-sections__item-description\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" data-v-9492fc08=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003eRetatrutide is an investigational synthetic peptide being studied as a \u003cstrong\u003etriple hormone receptor agonist\u003c\/strong\u003e, targeting \u003cstrong\u003eGIP, GLP-1, and glucagon receptors\u003c\/strong\u003e. This triple-action design makes it one of the most scientifically interesting compounds in current metabolic research because it engages three major pathways involved in appetite regulation, glucose control, insulin response, lipid metabolism, and energy expenditure.\u003c\/p\u003e\n\u003cp\u003eUnlike tirzepatide, which targets GIP and GLP-1, retatrutide adds glucagon receptor activity. In research, glucagon receptor activation is especially interesting because it may influence energy expenditure, fat metabolism, and liver-related metabolic pathways. This is why retatrutide is being studied not only for obesity and type 2 diabetes, but also for broader metabolic dysfunction research, including liver-fat-related outcomes. Phase 2 studies have reported meaningful weight-loss and glycemic improvements, but retatrutide remains investigational and is not an approved medication.\u003c\/p\u003e\n\u003ch3\u003ePotential benefits observed in human studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eVery strong body-weight reduction\u003c\/strong\u003e\u003cbr\u003eIn a phase 2 obesity trial, retatrutide produced large, dose-dependent body-weight reductions over 48 weeks, making it one of the most closely watched investigational metabolic peptides in clinical research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eTriple-pathway metabolic activity\u003c\/strong\u003e\u003cbr\u003eRetatrutide activates GIP, GLP-1, and glucagon receptors, giving researchers a way to study combined incretin and glucagon signaling in one molecule. This may help explain its strong effects on body-weight and metabolic markers.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAppetite and satiety effects\u003c\/strong\u003e\u003cbr\u003eGLP-1 and GIP receptor activity are associated with appetite signaling, food intake regulation, and satiety pathways. This makes retatrutide important for research into hunger control and long-term energy balance.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePossible increase in energy expenditure\u003c\/strong\u003e\u003cbr\u003eThe added glucagon receptor activity is scientifically important because glucagon signaling may influence energy use, lipid metabolism, and fat-burning pathways. This separates retatrutide from GLP-1-only and dual GIP\/GLP-1 compounds.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGlycemic control improvements\u003c\/strong\u003e\u003cbr\u003eIn people with type 2 diabetes, phase 2 research reported clinically meaningful improvements in glycemic control along with robust body-weight reductions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eInterest in liver-fat and metabolic dysfunction research\u003c\/strong\u003e\u003cbr\u003eRetatrutide has been highlighted in research involving obesity, type 2 diabetes, and NAFLD-related metabolic pathways, making it useful for studying how weight loss, glucose control, and liver-fat metabolism may connect.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOnce-weekly study design\u003c\/strong\u003e\u003cbr\u003eClinical studies have evaluated retatrutide as a once-weekly injectable investigational compound, which is relevant for pharmacokinetic and long-acting peptide research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePotential next-generation metabolic research model\u003c\/strong\u003e\u003cbr\u003eBecause it targets three receptors instead of one or two, retatrutide is often viewed as a next-generation research compound for studying multi-receptor metabolic signaling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed in human studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eStill investigational\u003c\/strong\u003e\u003cbr\u003eRetatrutide is not currently an approved medication. It is still being evaluated in clinical development, so its full long-term safety profile is not yet established.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGastrointestinal side effects may occur\u003c\/strong\u003e\u003cbr\u003eAs with GLP-1 and incretin-based compounds, nausea, vomiting, diarrhea, constipation, reduced appetite, and abdominal discomfort are commonly discussed side effects in this class of research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePotential for excessive weight loss\u003c\/strong\u003e\u003cbr\u003eBecause retatrutide has shown strong body-weight effects in studies, researchers and clinicians monitor concerns such as excessive weight reduction, loss of lean mass, nutritional issues, or tolerability problems.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMore complex mechanism\u003c\/strong\u003e\u003cbr\u003eTriple receptor activity may make results harder to interpret compared with single GLP-1 or dual GIP\/GLP-1 agonists. Effects may vary depending on dose, receptor expression, study population, and metabolic condition.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHuman use requires strict medical supervision\u003c\/strong\u003e\u003cbr\u003eSince retatrutide is investigational and not approved, it should not be used outside proper clinical research settings. Research-grade or unapproved products should not be used in humans.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eHuman clinical data on retatrutide is scientifically promising, especially for body-weight, glucose-control, and metabolic-pathway research. However, retatrutide remains investigational and should only be studied under appropriate research conditions. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 10mg","offer_id":51941113266464,"sku":null,"price":1800.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 15mg","offer_id":51941113299232,"sku":null,"price":2100.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 30mg","offer_id":51941113332000,"sku":null,"price":2700.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 15mg","offer_id":51941113364768,"sku":null,"price":3900.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 30mg","offer_id":51941113397536,"sku":null,"price":4400.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/63dc7560-b312-460e-a8f7-e3222dbd565e.png?v=1783190539"},{"product_id":"ghk-cu","title":"GHK-Cu (Copper-Binding Tripeptide | Skin \u0026 Tissue Remodeling Studies)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp class=\"additional-info-sections__item-description\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" data-v-9492fc08=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e, also known as copper tripeptide-1 or glycyl-L-histidyl-L-lysine copper complex, is an investigational copper-binding peptide commonly discussed in skin, hair, wound-healing, tissue-repair, and regenerative research. It is a naturally occurring tripeptide complex associated with copper signaling and is often studied for its possible relationship to extracellular matrix remodeling, collagen-related pathways, antioxidant response, and tissue-repair mechanisms. PubChem lists GHK-Cu as a copper peptide complex with the formula \u003cstrong\u003eC₂₈H₄₈CuN₁₂O₈\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eUnlike metabolic peptides such as tirzepatide, GHK-Cu is not designed around GLP-1, GIP, glucagon, appetite, or glucose-control receptor activity. Instead, scientific interest centers on copper-peptide signaling, skin-quality research, hair and follicle models, wound-healing investigation, connective-tissue support, inflammation-response pathways, and broader regenerative study. Reviews describe GHK-Cu as a peptide of interest in human skin research and tissue-regenerative mechanisms, while still emphasizing the need to avoid overextending claims beyond the available evidence.\u003c\/p\u003e\n\u003ch3\u003ePotential research interests observed in studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSkin and collagen research\u003c\/strong\u003e\u003cbr\u003eGHK-Cu is widely discussed in skin-related research involving collagen support, dermal remodeling, skin appearance, elasticity, and extracellular matrix activity. This is one of the most common areas where copper peptides are studied.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWound-healing and tissue-repair models\u003c\/strong\u003e\u003cbr\u003eResearch interest often focuses on wound-healing pathways, tissue-repair signaling, and recovery-related mechanisms. Reviews describe GHK-Cu as a copper peptide associated with regenerative and protective actions in skin and tissue models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHair and follicle research\u003c\/strong\u003e\u003cbr\u003eGHK-Cu is frequently discussed in relation to scalp, follicle, and hair-support research. These discussions are mainly investigational and should not be presented as proven treatment outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eConnective-tissue support research\u003c\/strong\u003e\u003cbr\u003eBecause GHK-Cu is associated with matrix remodeling and collagen-related pathways, it is often studied in broader connective-tissue and tissue-quality research contexts.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCopper-peptide signaling\u003c\/strong\u003e\u003cbr\u003eGHK-Cu is studied as a copper-binding peptide complex, which makes it relevant to research involving copper transport, peptide-metal coordination, cellular signaling, and redox-related mechanisms.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAntioxidant and inflammation-response research\u003c\/strong\u003e\u003cbr\u003eScientific discussion around GHK-Cu often includes antioxidant response, inflammatory signaling, and tissue-stress pathways. These findings should be understood as research interests, not confirmed clinical benefits.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCosmetic and dermatology research interest\u003c\/strong\u003e\u003cbr\u003eGHK-Cu has a long history of discussion in cosmetic science, especially around skin-aging, texture, and appearance-related research. Public interest has grown, but many consumer-facing claims still exceed what controlled clinical evidence can firmly establish.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eStable topical-research interest\u003c\/strong\u003e\u003cbr\u003eGHK-Cu is commonly discussed in topical and cosmetic research contexts because of its copper-peptide identity and skin-focused study history. Injectable or unapproved human use should not be implied or promoted.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed or discussed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHuman clinical evidence is still limited\u003c\/strong\u003e\u003cbr\u003eAlthough GHK-Cu has more cosmetic and skin-related research history than many newer peptides, broad human claims around skin regeneration, hair growth, anti-aging, wound healing, or systemic benefits still require stronger controlled clinical evidence.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNot an approved medication for disease treatment\u003c\/strong\u003e\u003cbr\u003eGHK-Cu should not be marketed as a treatment for wounds, hair loss, skin disease, scarring, inflammation, injury recovery, or any medical condition.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRoute of use matters\u003c\/strong\u003e\u003cbr\u003eTopical cosmetic discussion is different from injection or systemic exposure. Research-grade or unapproved peptide products should not be used in humans, especially by injection.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePossible irritation or sensitivity\u003c\/strong\u003e\u003cbr\u003eCopper peptide products may cause irritation, sensitivity, redness, or other local reactions in some topical-use contexts. These risks may vary depending on concentration, formulation, and individual skin response.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCopper-related formulation concerns\u003c\/strong\u003e\u003cbr\u003eBecause GHK-Cu involves copper complexation, improper formulation, instability, concentration errors, or contamination may affect product quality and safety.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePossible risks from unregulated products\u003c\/strong\u003e\u003cbr\u003eProducts sold online as research chemicals may carry risks related to contamination, inaccurate concentration, mislabeling, sterility issues, or lack of regulated manufacturing oversight.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eClaims may exceed the evidence\u003c\/strong\u003e\u003cbr\u003eMany online claims around \"anti-aging,\" \"hair growth,\" \"scar repair,\" \"skin regeneration,\" or \"wound healing\" go beyond what has been proven in controlled human trials.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eGHK-Cu is scientifically interesting for copper-peptide signaling, skin, hair, wound-healing, connective-tissue, and regenerative research, but broad human safety and effectiveness claims remain insufficiently established. GHK-Cu should not be marketed as a treatment for any medical condition, and unapproved human use should be avoided. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 50mg","offer_id":51941115167008,"sku":null,"price":1300.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 100mg","offer_id":51941115199776,"sku":null,"price":1400.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 50mg","offer_id":51941115265312,"sku":null,"price":3000.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 100mg","offer_id":51941115298080,"sku":null,"price":3100.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/f169acc0-1f0d-433d-b982-8b10cc1a3366_1944fc4e-5c64-4d02-b543-9c3be3d9378d.png?v=1783191000"},{"product_id":"cjc-1295-no-dac-ipamorelin","title":"CJC-1295 (No DAC) + Ipamorelin (GHRH Analog + Ghrelin Mimetic Blend | Growth Hormone Pathway Research)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp data-v-9492fc08=\"\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" class=\"additional-info-sections__item-description\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCJC-1295 No DAC + Ipamorelin\u003c\/strong\u003e is an investigational peptide blend commonly discussed in research settings for its potential relevance to growth-hormone secretagogue pathways, recovery-related models, sleep-associated protocols, and body-composition research. This blend typically combines \u003cstrong\u003eCJC-1295 without DAC\u003c\/strong\u003e, a short-acting growth hormone–releasing hormone analog, with \u003cstrong\u003eIpamorelin\u003c\/strong\u003e, a growth hormone secretagogue often studied for its selective ghrelin-receptor activity.\u003c\/p\u003e\n\u003cp\u003eUnlike metabolic peptides such as tirzepatide or retatrutide, CJC-1295 No DAC + Ipamorelin is not designed around GLP-1, GIP, or glucagon receptor activity. Instead, scientific interest centers on growth hormone pulse signaling, GH\/IGF-1 axis research, recovery-related experimental models, sleep-timing protocols, and broader body-composition investigation.\u003c\/p\u003e\n\u003cp\u003eCJC-1295 and Ipamorelin remain investigational in many contexts and should not be marketed as treatments for fat loss, muscle growth, anti-aging, sleep disorders, injury recovery, or hormone deficiency. Both compounds are also listed under the World Anti-Doping Agency's prohibited framework: WADA names CJC-1295 among GHRH analogues and Ipamorelin among growth hormone secretagogues.\u003c\/p\u003e\n\u003ch3\u003ePotential research interests observed or discussed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGrowth hormone pulse research\u003c\/strong\u003e\u003cbr\u003eCJC-1295 No DAC and Ipamorelin are commonly discussed in experimental models involving pulsatile growth hormone release, secretagogue activity, and GH-axis signaling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGH\/IGF-1 axis investigation\u003c\/strong\u003e\u003cbr\u003eBecause the blend is often studied in relation to growth hormone signaling, research interest frequently extends to IGF-1 response, endocrine feedback, and related pathway analysis.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSleep and nighttime protocol interest\u003c\/strong\u003e\u003cbr\u003eIpamorelin and CJC-1295 No DAC are often presented in research-oriented protocols involving pre-sleep timing, overnight hormone-pulse modeling, and recovery-associated sleep research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRecovery-oriented experimental models\u003c\/strong\u003e\u003cbr\u003eThis blend is frequently discussed in peptide research communities for experimental models involving training recovery, tissue stress response, and restoration-related pathways.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eBody-composition research\u003c\/strong\u003e\u003cbr\u003eCJC-1295 No DAC + Ipamorelin is often studied in broader investigational contexts related to lean-mass support, fat-loss protocol interest, metabolic signaling, and performance-related research discussions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSelective secretagogue interest\u003c\/strong\u003e\u003cbr\u003eIpamorelin is often described as a growth hormone secretagogue with research interest around selective ghrelin-receptor activity and GH-release signaling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eShort-acting protocol interest\u003c\/strong\u003e\u003cbr\u003eCJC-1295 No DAC is commonly differentiated from DAC-containing versions because it is discussed as a shorter-acting GHRH analog, making it a frequent subject in pulse-oriented research protocols.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eBlend-format research interest\u003c\/strong\u003e\u003cbr\u003eThe 5 mg \/ 5 mg blend format is commonly discussed because it combines a GHRH analog with a GHS-style peptide, allowing researchers to evaluate combined secretagogue-pathway interest in a single formulation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed or discussed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eLimited human clinical evidence\u003c\/strong\u003e\u003cbr\u003eMuch of the public discussion around CJC-1295 No DAC + Ipamorelin extends beyond the level of controlled human clinical evidence available. More well-designed human trials are needed before safety, dosing, or effectiveness claims can be established.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNot an FDA-approved medication\u003c\/strong\u003e\u003cbr\u003eCJC-1295 No DAC + Ipamorelin should not be represented as an FDA-approved treatment for anti-aging, fat loss, muscle growth, sleep, injury recovery, or hormone optimization. Reports on peptide regulation continue to note the distinction between compounded or research-market availability and formal FDA approval.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eUnknown long-term safety profile\u003c\/strong\u003e\u003cbr\u003eBecause controlled long-term human data are limited, the long-term safety profile, interaction risks, appropriate populations, and contraindications are not fully established.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHormone-axis concerns\u003c\/strong\u003e\u003cbr\u003eBecause this blend is discussed in relation to GH and IGF-1 signaling, inappropriate use may raise concerns around endocrine disruption, abnormal hormone levels, glucose metabolism, fluid retention, or other hormone-related effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAthlete compliance concerns\u003c\/strong\u003e\u003cbr\u003eCJC-1295 and Ipamorelin are prohibited in sport under WADA's peptide hormone and growth hormone secretagogue categories, creating significant compliance concerns for tested athletes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eClaims may exceed the evidence\u003c\/strong\u003e\u003cbr\u003eMany online claims around \"anti-aging,\" \"fat loss,\" \"muscle growth,\" \"sleep improvement,\" or \"recovery enhancement\" go beyond what has been proven in controlled human trials.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHuman use requires medical and regulatory caution\u003c\/strong\u003e\u003cbr\u003eBecause this blend remains investigational in many contexts, it should only be handled under appropriate research conditions and should not be used as a substitute for approved medical care.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eCJC-1295 No DAC + Ipamorelin 5 mg \/ 5 mg blend is scientifically interesting for growth hormone secretagogue, recovery-related, sleep-timing, and body-composition research, but human safety and effectiveness remain insufficiently established. This blend is not approved for human clinical use as a treatment and should only be studied under appropriate research conditions. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 5mg+5m (10mg Blend)","offer_id":51941119656224,"sku":null,"price":2200.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 5mg+5m (10mg Blend)","offer_id":51941119721760,"sku":null,"price":3900.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/ChatGPTImageMay25_2026_01_35_38AM_2.png?v=1783191425"},{"product_id":"tesamorelin","title":"Tesamorelin (Growth Hormone–Releasing Hormone Analog | Endogenous GH Release Research)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp data-v-9492fc08=\"\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" class=\"additional-info-sections__item-description\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTesamorelin\u003c\/strong\u003e is an investigational growth hormone–releasing hormone analog commonly discussed in research settings for its relationship to endogenous growth hormone release, GH\/IGF-1 axis activity, body-composition research, visceral-fat reduction, recovery-oriented models, and sleep-associated protocols. It is a synthetic analog of human GHRH designed to stimulate the body's own growth hormone signaling pathway rather than acting as a direct growth hormone replacement.\u003c\/p\u003e\n\u003cp\u003eUnlike metabolic peptides such as tirzepatide or retatrutide, Tesamorelin is not designed around GLP-1, GIP, glucagon, appetite, or glucose-control receptor activity. Instead, scientific interest centers on GHRH receptor signaling, natural GH pulse stimulation, IGF-1 response, body-composition changes, lean-mass research, visceral-fat studies, sleep-timing protocols, and broader metabolic-health investigation.\u003c\/p\u003e\n\u003cp\u003eTesamorelin is best known in clinical research for its association with visceral adipose tissue reduction in specific studied populations. In broader peptide research discussions, it is often referenced for GH-axis support, physique-oriented research, recovery-related pathways, and nighttime protocol interest. Claims around muscle growth, fat loss, sleep improvement, or anti-aging should still be presented carefully and not overstated beyond the evidence.\u003c\/p\u003e\n\u003ch3\u003ePotential research interests observed in studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGH\/IGF-1 axis research\u003c\/strong\u003e\u003cbr\u003eTesamorelin is widely discussed for its ability to stimulate growth hormone–releasing hormone receptor activity, leading to increased endogenous growth hormone pulse signaling and downstream IGF-1 response. This makes it a major peptide of interest in GH-axis and endocrine-pathway research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eBody-composition research\u003c\/strong\u003e\u003cbr\u003eTesamorelin is commonly associated with body-composition investigation, especially research involving visceral adipose tissue, abdominal fat distribution, lean-mass balance, and metabolic-profile changes. This is one of the most recognized areas of Tesamorelin research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eVisceral-fat research focus\u003c\/strong\u003e\u003cbr\u003eA major area of scientific interest involves Tesamorelin's relationship to visceral-fat reduction in studied clinical settings. Because visceral adipose tissue is closely tied to metabolic health markers, Tesamorelin continues to receive attention in body-composition and cardiometabolic research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eLean-mass and muscle-support interest\u003c\/strong\u003e\u003cbr\u003eBecause Tesamorelin acts through the GH\/IGF-1 axis, researchers often discuss it in relation to lean tissue, muscle-protein signaling, recovery support, and physique-oriented study models. These areas should be framed as investigational research interests rather than guaranteed muscle-growth outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRecovery-oriented research\u003c\/strong\u003e\u003cbr\u003eTesamorelin is frequently discussed in peptide research communities for its possible relationship to recovery pathways, tissue maintenance, training adaptation, and restoration-related mechanisms. This interest is largely connected to broader GH\/IGF-1 signaling research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSleep and nighttime protocol interest\u003c\/strong\u003e\u003cbr\u003eGrowth hormone secretion is naturally associated with sleep cycles, especially deeper sleep stages. Because Tesamorelin is a GHRH analog, it is often discussed in nighttime research protocols involving pre-sleep timing, fasted administration models, overnight GH pulse interest, and sleep-associated recovery research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMetabolic-marker investigation\u003c\/strong\u003e\u003cbr\u003eTesamorelin research often includes interest in metabolic markers such as waist circumference, lipid-related parameters, insulin sensitivity, glucose metabolism, and broader cardiometabolic profile observations. These outcomes can vary depending on study population and protocol.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNatural GH pulse stimulation\u003c\/strong\u003e\u003cbr\u003eUnlike direct growth hormone administration, Tesamorelin is researched for stimulating endogenous growth hormone release through the GHRH pathway. This makes it scientifically interesting for pulse-oriented hormone research and endocrine feedback models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePhysique and performance-support research\u003c\/strong\u003e\u003cbr\u003eIn research-oriented discussions, Tesamorelin is often associated with abdominal-fat reduction, lean-mass interest, improved body composition, recovery timing, and performance-support models. These should be described as research interests, not approved claims for athletic enhancement.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed or discussed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHuman evidence depends on study context\u003c\/strong\u003e\u003cbr\u003eTesamorelin has been studied in human clinical settings, but results and approved-use contexts are specific. Broader claims around muscle growth, fat loss, sleep improvement, anti-aging, or general performance enhancement should not be presented as universally proven.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNot a general-purpose weight-loss or muscle-growth product\u003c\/strong\u003e\u003cbr\u003eTesamorelin should not be marketed as a general fat-loss drug, bodybuilding product, sleep aid, anti-aging therapy, or muscle-growth treatment. Research discussion should remain focused on GH\/IGF-1 axis, body-composition, and visceral-fat study contexts.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRequires medical supervision when used clinically\u003c\/strong\u003e\u003cbr\u003eIn approved medical contexts, Tesamorelin use requires professional oversight. Research-grade or unapproved peptide products should not be used in humans or represented as substitutes for regulated medication.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHormone-axis concerns\u003c\/strong\u003e\u003cbr\u003eBecause Tesamorelin affects GH and IGF-1 signaling, inappropriate use may raise concerns around elevated IGF-1, fluid retention, joint discomfort, glucose changes, numbness or tingling, carpal-tunnel-like symptoms, and other hormone-related effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGlucose and insulin-sensitivity considerations\u003c\/strong\u003e\u003cbr\u003eGH-axis modulation may influence glucose metabolism in some settings. Research discussions around Tesamorelin should account for possible changes in blood sugar, insulin response, and metabolic risk factors.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eUnknown long-term safety for unapproved use\u003c\/strong\u003e\u003cbr\u003eLong-term safety, dose-response, interaction risks, risk groups, and appropriate monitoring are not fully established for unapproved or research-grade use outside regulated clinical settings.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eClaims may exceed the evidence\u003c\/strong\u003e\u003cbr\u003eMany online claims around \"muscle growth,\" \"deep sleep,\" \"fat loss,\" \"anti-aging,\" \"recovery,\" or \"performance enhancement\" go beyond what can be responsibly claimed without controlled clinical evidence in the relevant population.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTesamorelin is scientifically interesting for GHRH receptor signaling, endogenous growth hormone release, GH\/IGF-1 axis research, visceral-fat investigation, body-composition studies, lean-mass interest, recovery-related models, and sleep-timing protocols. While research around Tesamorelin is promising in specific contexts, broad claims around muscle growth, fat loss, sleep improvement, or anti-aging should not be overstated. Tesamorelin should only be studied under appropriate research conditions. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 20mg","offer_id":51941133254944,"sku":null,"price":3600.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 20mg","offer_id":51941133287712,"sku":null,"price":4600.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/21224e6c-c372-468b-8ce1-c978826a5d86_72b8e527-b4e1-46ea-bcfd-5fcb9f7fb21d.png?v=1783192252"},{"product_id":"bpc-157","title":"BPC-157 (Pentadecapeptide BPC-157 | Tissue \u0026 Repair Pathway Research)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp data-v-9492fc08=\"\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" class=\"additional-info-sections__item-description\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e is an investigational synthetic peptide being studied for its potential role in tissue-repair, gastrointestinal, and recovery-related research. It is a 15–amino-acid peptide, often described as a \"body protection compound,\" and is mainly discussed in preclinical research models involving soft tissue, tendon, ligament, muscle, wound-healing, and gut-barrier pathways.\u003c\/p\u003e\n\u003cp\u003eUnlike metabolic peptides such as tirzepatide or retatrutide, BPC-157 is not designed around GLP-1, GIP, or glucagon receptor activity. Instead, scientific interest centers on its possible interaction with repair-related signaling, angiogenesis, nitric oxide pathways, inflammation response, and gastrointestinal protection mechanisms. Most published evidence is still based on animal and laboratory studies, and researchers continue to emphasize the need for well-designed human trials before safety or effectiveness can be established.\u003c\/p\u003e\n\u003cp\u003eBPC-157 remains investigational and is not approved for human clinical use by major regulatory authorities. It is also prohibited in sport under the World Anti-Doping Agency framework as an unapproved substance.\u003c\/p\u003e\n\u003ch3\u003ePotential research interests observed mainly in preclinical studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eTissue-repair research\u003c\/strong\u003e\u003cbr\u003eBPC-157 is widely discussed in animal and laboratory research involving tendon, ligament, muscle, and wound-healing models. This has made it one of the most commonly referenced peptides in repair and recovery research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGastrointestinal support research\u003c\/strong\u003e\u003cbr\u003eBecause BPC-157 is associated with gastric-protection models, it is often studied in relation to gut integrity, ulcer models, intestinal injury, and gastrointestinal barrier research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSoft-tissue and musculoskeletal interest\u003c\/strong\u003e\u003cbr\u003eResearch attention often focuses on connective-tissue models, including tendons, ligaments, and muscle injury pathways. A recent review noted strong preclinical interest but also emphasized that human evidence remains limited.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eInflammation-response research\u003c\/strong\u003e\u003cbr\u003eBPC-157 is often discussed in experimental models involving inflammatory signaling and tissue-stress response. These findings are not the same as proven clinical benefits in humans.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eBlood-flow and angiogenesis-related pathways\u003c\/strong\u003e\u003cbr\u003eSome studies examine BPC-157 in relation to nitric oxide signaling, vascular response, and blood-vessel formation during tissue-repair models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRecovery-oriented experimental models\u003c\/strong\u003e\u003cbr\u003eBPC-157 is commonly researched in models involving injury response, recovery timing, and tissue-protection mechanisms, which explains its popularity in peptide research communities.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eStable peptide structure\u003c\/strong\u003e\u003cbr\u003eBPC-157 is frequently described as a relatively stable peptide sequence, which is one reason it continues to receive attention in laboratory and preclinical research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eBroad investigational use\u003c\/strong\u003e\u003cbr\u003eBecause it is studied across gut, tissue, tendon, and wound-repair models, BPC-157 is often viewed as a broad research peptide rather than a pathway-specific metabolic peptide.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed or discussed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eLimited human clinical evidence\u003c\/strong\u003e\u003cbr\u003eMost BPC-157 findings come from animal or laboratory studies. Current reviews highlight the need for well-designed human trials before claims about safety, dosing, or effectiveness can be made.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNot an approved medication\u003c\/strong\u003e\u003cbr\u003eBPC-157 is not approved for human clinical use by major regulatory authorities. It should not be marketed or used as a treatment for injury, pain, gut disease, or recovery.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eUnknown long-term safety profile\u003c\/strong\u003e\u003cbr\u003eBecause controlled human research is limited, long-term safety, drug interactions, appropriate dosing, and risk groups are not well established.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAthlete compliance concerns\u003c\/strong\u003e\u003cbr\u003eBPC-157 is prohibited under WADA's prohibited framework, and USADA warns that it is an experimental peptide not approved for human clinical use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eClaims may exceed the evidence\u003c\/strong\u003e\u003cbr\u003eMany online claims around \"healing,\" \"injury repair,\" or \"gut repair\" go beyond what has been proven in controlled human trials.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHuman use requires medical and regulatory caution\u003c\/strong\u003e\u003cbr\u003eBecause BPC-157 remains investigational, it should only be handled within appropriate research settings and should not be used as a substitute for approved medical care.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157 is scientifically interesting for tissue-repair, gastrointestinal, and recovery-related research, but current evidence is primarily preclinical and its human safety profile remains insufficiently established. BPC-157 is not approved for human clinical use and should only be studied under appropriate research conditions. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 10mg","offer_id":51941135089952,"sku":null,"price":1700.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 10mg","offer_id":51941135122720,"sku":null,"price":3400.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/ChatGPTImageMay25_2026_01_35_37AM_1.png?v=1783192363"},{"product_id":"tb-500","title":"TB-500 (Synthetic Thymosin β-4 Fragment | Tissue Repair \u0026 Inflammation Studies)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp class=\"additional-info-sections__item-description\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" data-v-9492fc08=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e is an investigational synthetic peptide commonly discussed in research settings for its relationship to tissue-repair models, actin regulation, cell migration, angiogenesis, inflammation-modulation pathways, recovery-oriented studies, and connective-tissue research. It is commonly described as a synthetic fragment associated with thymosin beta-4 research, a naturally occurring peptide involved in cellular repair signaling, cytoskeletal organization, and tissue remodeling processes.\u003c\/p\u003e\n\u003cp\u003eUnlike metabolic peptides such as tirzepatide or retatrutide, TB-500 is not designed around GLP-1, GIP, glucagon, appetite, or glucose-control receptor activity. Unlike GH secretagogues such as Ipamorelin, CJC-1295, Tesamorelin, or Sermorelin, TB-500 is not primarily studied for growth-hormone release or GH\/IGF-1 axis stimulation. Instead, scientific interest centers on actin-binding activity, cellular migration, tissue-remodeling pathways, angiogenesis research, inflammation-response models, wound-healing investigation, tendon and ligament research, and broader recovery-related biological processes.\u003c\/p\u003e\n\u003cp\u003eTB-500 is frequently discussed in peptide research communities alongside other recovery-oriented compounds because of its connection to thymosin beta-4 biology and tissue-repair signaling. Research interest is generally focused on cellular and connective-tissue models rather than direct hormone modulation, appetite regulation, or metabolic receptor targeting.\u003c\/p\u003e\n\u003ch3\u003ePotential research interests observed in studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eTissue-repair research\u003c\/strong\u003e\u003cbr\u003eTB-500 is widely discussed for its relationship to tissue-repair models, especially research involving cellular movement, tissue remodeling, and wound-healing mechanisms. Scientific interest often centers on how thymosin beta-4-related peptides may influence biological repair pathways in controlled research settings.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eActin regulation and cell-migration research\u003c\/strong\u003e\u003cbr\u003eA key area of TB-500 research involves actin regulation. Actin is an important structural protein involved in cell movement, cytoskeletal organization, and tissue remodeling. TB-500 is commonly discussed in relation to actin-binding activity and cellular migration models, which makes it a peptide of interest in tissue-repair and regenerative research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eTendon and ligament research\u003c\/strong\u003e\u003cbr\u003eTB-500 is frequently associated with tendon, ligament, and connective-tissue research. In peptide research communities, it is often discussed for its potential relevance to models involving soft-tissue repair, connective-tissue remodeling, and recovery-oriented investigation. These areas should be framed as investigational research interests rather than confirmed treatment outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWound-healing and remodeling models\u003c\/strong\u003e\u003cbr\u003eBecause thymosin beta-4 biology is associated with cell migration and tissue organization, TB-500 is often discussed in wound-healing research models. Scientific interest may include epithelial repair, extracellular matrix remodeling, cellular recruitment, and broader tissue-regeneration pathways.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAngiogenesis research\u003c\/strong\u003e\u003cbr\u003eTB-500 is commonly discussed in research involving angiogenesis, or the formation of new blood vessels. This area of interest is related to tissue-repair models because vascular remodeling and blood-flow support are important components of many biological recovery processes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eInflammation-modulation investigation\u003c\/strong\u003e\u003cbr\u003eTB-500 is often studied or discussed in relation to inflammation-response models. Research interest may include how thymosin beta-4-related pathways interact with inflammatory signaling, tissue-protective mechanisms, and repair-associated immune activity. These discussions should remain research-focused and should not be presented as proven anti-inflammatory treatment claims.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRecovery-oriented research\u003c\/strong\u003e\u003cbr\u003eTB-500 is frequently discussed in peptide research communities for its possible relationship to recovery pathways, tissue maintenance, and restoration-related biological processes. This interest is commonly connected to soft-tissue models, connective-tissue remodeling, cellular repair activity, and post-stress biological recovery research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePerformance-support research\u003c\/strong\u003e\u003cbr\u003eIn research-oriented discussions, TB-500 is often associated with recovery timing, tissue resilience, mobility-related study models, and performance-support investigation. These should be described as research interests, not approved claims for athletic enhancement, injury treatment, or improved physical performance.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSkin, hair, and regenerative-biology interest\u003c\/strong\u003e\u003cbr\u003eBecause thymosin beta-4 biology has been explored in tissue-repair and regenerative models, TB-500 is sometimes discussed in relation to skin, hair-follicle, and epithelial-repair research. These areas remain investigational and should not be framed as guaranteed cosmetic, dermatologic, or regenerative outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed or discussed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eUnknown long-term safety for unapproved use\u003c\/strong\u003e\u003cbr\u003eLong-term safety, dose-response, interaction risks, risk groups, and appropriate monitoring are not fully established for unapproved or research-grade use outside regulated clinical settings. TB-500 should be discussed as an investigational research compound, not as an approved therapeutic product.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eTissue-growth and angiogenesis concerns\u003c\/strong\u003e\u003cbr\u003eBecause TB-500 is commonly discussed in relation to cell migration, tissue remodeling, and angiogenesis, inappropriate use may raise theoretical concerns around unwanted tissue activity, abnormal repair signaling, or risks in settings where excessive cellular growth or vascular activity would be undesirable. These concerns should be considered in research design and interpretation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eImmune and inflammation-response considerations\u003c\/strong\u003e\u003cbr\u003eResearch involving inflammation modulation, immune signaling, or tissue-protective pathways can be complex. Outcomes may vary depending on model type, study duration, concentration, route of exposure, and biological context.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eLack of approved clinical-use framework\u003c\/strong\u003e\u003cbr\u003eTB-500 does not have the same established clinical-use framework as approved medications. Claims around healing, injury recovery, pain relief, mobility, performance, or anti-aging should not be overstated or presented as established outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePossible risks from unregulated products\u003c\/strong\u003e\u003cbr\u003eProducts sold online as research chemicals may carry risks related to contamination, inaccurate concentration, mislabeling, sterility issues, improper storage, or lack of regulated manufacturing oversight.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTB-500 is scientifically interesting for thymosin beta-4-related research, actin regulation, cell-migration models, tissue-remodeling pathways, angiogenesis investigation, connective-tissue research, recovery-oriented models, and inflammation-response studies. While research around TB-500 is promising in specific controlled contexts, broad claims around injury healing, pain relief, athletic performance, anti-aging, skin repair, or tissue regeneration should not be overstated. TB-500 should only be studied under appropriate research conditions. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 5mg","offer_id":51941136204064,"sku":null,"price":1700.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 5mg","offer_id":51941136236832,"sku":null,"price":3400.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/ChatGPTImageMay25_2026_11_52_56PM_1.png?v=1783192602"},{"product_id":"mots-c","title":"MOTS-C (Synthetic Mitochondrial-Derived Peptide | Metabolic, Cellular Energy \u0026 AMPK Signaling Studies)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp class=\"additional-info-sections__item-description\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" data-v-9492fc08=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMOTS-C\u003c\/strong\u003e is an investigational synthetic peptide commonly discussed in research settings for its relationship to mitochondrial signaling, metabolic regulation, cellular energy balance, AMPK pathway activity, insulin-sensitivity models, exercise-mimetic research, and healthy-aging investigation. It is commonly described as a mitochondrial-derived peptide associated with the mitochondrial open reading frame of the 12S rRNA-c, a small peptide sequence studied for its role in cellular stress response, metabolic adaptation, and energy-homeostasis pathways.\u003c\/p\u003e\n\u003cp\u003eUnlike tissue-repair peptides such as TB-500 or BPC-157, MOTS-C is not primarily designed around connective-tissue remodeling, actin regulation, tendon research, or wound-healing models. Unlike GH secretagogues such as Ipamorelin, CJC-1295, Tesamorelin, or Sermorelin, MOTS-C is not primarily studied for growth-hormone release or GH\/IGF-1 axis stimulation. Instead, scientific interest centers on mitochondrial communication, AMPK activation, glucose-utilization research, insulin-signaling models, metabolic flexibility, exercise-mimetic pathways, cellular stress adaptation, and broader metabolic-health investigation.\u003c\/p\u003e\n\u003cp\u003eMOTS-C is frequently discussed in peptide research communities alongside other metabolic and longevity-oriented compounds because of its connection to mitochondrial function and cellular energy regulation. Research interest is generally focused on metabolic signaling and mitochondrial-derived peptide biology rather than direct hormone modulation, appetite suppression, or tissue-repair targeting.\u003c\/p\u003e\n\u003ch3\u003ePotential research interests observed in studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMetabolic-health research\u003c\/strong\u003e\u003cbr\u003eMOTS-C is widely discussed for its relationship to metabolic-health models, especially research involving glucose utilization, energy balance, insulin signaling, and substrate metabolism. Scientific interest often centers on how mitochondrial-derived peptides may influence adaptive metabolic pathways in controlled research settings.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAMPK signaling research\u003c\/strong\u003e\u003cbr\u003eA key area of MOTS-C research involves AMPK signaling. AMPK is an important cellular energy-sensing pathway involved in metabolic regulation, glucose uptake, fatty-acid oxidation, and cellular stress response. MOTS-C is commonly discussed in relation to AMPK pathway activity, which makes it a peptide of interest in metabolic and cellular-energy research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eInsulin-sensitivity and glucose-utilization research\u003c\/strong\u003e\u003cbr\u003eMOTS-C is frequently associated with insulin-sensitivity and glucose-metabolism research. In peptide research communities, it is often discussed for its potential relevance to models involving glucose uptake, insulin signaling, metabolic flexibility, and energy-homeostasis pathways. These areas should be framed as investigational research interests rather than confirmed therapeutic outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMitochondrial function and cellular-energy models\u003c\/strong\u003e\u003cbr\u003eBecause MOTS-C is classified as a mitochondrial-derived peptide, it is often discussed in research models involving mitochondrial communication, cellular energy regulation, oxidative stress response, and metabolic adaptation. Scientific interest may include mitochondrial signaling, cellular resilience, and energy-production pathway investigation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eExercise-mimetic research\u003c\/strong\u003e\u003cbr\u003eMOTS-C is commonly discussed in research involving exercise-mimetic pathways, or biological signaling patterns that overlap with certain exercise-associated metabolic adaptations. This area of interest is related to AMPK activity, endurance models, glucose handling, and cellular stress-response research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHealthy-aging investigation\u003c\/strong\u003e\u003cbr\u003eMOTS-C is often studied or discussed in relation to aging biology and cellular resilience models. Research interest may include mitochondrial stress response, age-associated metabolic changes, cellular adaptation, and pathways connected to metabolic healthspan. These discussions should remain research-focused and should not be presented as proven anti-aging claims.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eBody-composition and metabolic-flexibility research\u003c\/strong\u003e\u003cbr\u003eMOTS-C is frequently discussed in peptide research communities for its possible relationship to body-composition models, substrate utilization, energy expenditure, and metabolic flexibility. This interest is commonly connected to broader mitochondrial and AMPK-related signaling research rather than direct fat-loss or muscle-growth claims.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePerformance and endurance research\u003c\/strong\u003e\u003cbr\u003eIn research-oriented discussions, MOTS-C is often associated with endurance models, exercise adaptation, cellular energy availability, and performance-support investigation. These should be described as research interests, not approved claims for athletic enhancement, stamina improvement, or physical performance outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCellular stress and inflammation-response interest\u003c\/strong\u003e\u003cbr\u003eBecause mitochondrial signaling is closely connected to cellular stress pathways, MOTS-C is sometimes discussed in relation to oxidative stress, inflammatory signaling, and cellular-protection models. These areas remain investigational and should not be framed as guaranteed anti-inflammatory, protective, or regenerative outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed or discussed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eUnknown long-term safety for unapproved use\u003c\/strong\u003e\u003cbr\u003eLong-term safety, dose-response, interaction risks, risk groups, and appropriate monitoring are not fully established for unapproved or research-grade use outside regulated clinical settings. MOTS-C should be discussed as an investigational research compound, not as an approved therapeutic product.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMetabolic and glucose-regulation concerns\u003c\/strong\u003e\u003cbr\u003eBecause MOTS-C is commonly discussed in relation to glucose utilization, insulin signaling, AMPK activity, and metabolic regulation, inappropriate use may raise concerns around unexpected metabolic changes, altered glucose handling, or risks in settings involving metabolic disease, medication interactions, or impaired energy regulation. These concerns should be considered in research design and interpretation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCellular-stress and mitochondrial-pathway considerations\u003c\/strong\u003e\u003cbr\u003eResearch involving mitochondrial signaling, AMPK activation, oxidative stress, or cellular adaptation can be complex. Outcomes may vary depending on model type, study duration, concentration, route of exposure, biological context, and baseline metabolic status.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eLack of approved clinical-use framework\u003c\/strong\u003e\u003cbr\u003eMOTS-C does not have the same established clinical-use framework as approved medications. Claims around fat loss, glucose control, endurance, anti-aging, mitochondrial enhancement, insulin sensitivity, or metabolic improvement should not be overstated or presented as established outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eMOTS-C is scientifically interesting for mitochondrial-derived peptide research, AMPK signaling, cellular-energy regulation, glucose-utilization models, insulin-sensitivity research, metabolic-flexibility studies, exercise-mimetic pathways, cellular stress-response models, and healthy-aging investigation. While research around MOTS-C is promising in specific controlled contexts, broad claims around fat loss, blood sugar control, athletic performance, endurance, anti-aging, mitochondrial enhancement, or disease treatment should not be overstated. MOTS-C should only be studied under appropriate research conditions. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 10mg","offer_id":51941136859424,"sku":null,"price":1700.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 10mg","offer_id":51941136892192,"sku":null,"price":3400.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/ChatGPTImageMay26_2026_12_28_22AM_4.png?v=1783192736"},{"product_id":"ipamorelin","title":"Ipamorelin (Pentapeptide Ipamorelin | GH Secretagogue Pathway Research)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp data-v-9492fc08=\"\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" class=\"additional-info-sections__item-description\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIpamorelin\u003c\/strong\u003e is an investigational growth hormone secretagogue peptide commonly discussed in research settings for its relationship to endogenous growth hormone release, GH\/IGF-1 axis activity, body-composition research, recovery-oriented models, and sleep-associated protocols. It is a selective synthetic pentapeptide designed to stimulate the body's own growth hormone signaling pathway through the ghrelin\/GH secretagogue receptor rather than acting as a direct growth hormone replacement.\u003c\/p\u003e\n\u003cp\u003eUnlike metabolic peptides such as tirzepatide or retatrutide, Ipamorelin is not designed around GLP-1, GIP, glucagon, appetite, or glucose-control receptor activity. Instead, scientific interest centers on GH secretagogue receptor signaling, natural GH pulse stimulation, IGF-1 response, body-composition changes, lean-mass research, sleep-timing protocols, and broader metabolic-health investigation. Ipamorelin is frequently discussed in research communities alongside GHRH analogs such as CJC-1295, Tesamorelin, and Sermorelin, as GH secretagogues and GHRH analogs are considered to act synergistically — one stimulating GH release through the secretagogue receptor pathway while the other amplifies it through GHRH receptor signaling.\u003c\/p\u003e\n\u003ch3\u003ePotential research interests observed in studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGH\/IGF-1 axis research\u003c\/strong\u003e\u003cbr\u003eIpamorelin is widely discussed for its ability to stimulate GH secretagogue receptor activity, leading to increased endogenous growth hormone pulse signaling and downstream IGF-1 response. This makes it a major peptide of interest in GH-axis and endocrine-pathway research. Its selectivity for GH release — with limited crossover into cortisol or prolactin pathways at studied doses — is a frequently noted research characteristic.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGHRH analog combination research\u003c\/strong\u003e\u003cbr\u003eA key area of interest in the peptide research community involves the combination of Ipamorelin with GHRH analogs. Because Ipamorelin acts through a complementary receptor pathway to GHRH agonists, researchers often study it alongside CJC-1295, Tesamorelin, or Sermorelin. These pairings are investigated for their potential to produce amplified GH pulse activity relative to either compound used alone — a model based on the dual-pathway stimulation of endogenous GH release.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eBody-composition research\u003c\/strong\u003e\u003cbr\u003eIpamorelin is commonly associated with body-composition investigation, especially research involving lean-mass balance, adipose tissue dynamics, and metabolic-profile changes. This is one of the most recognized areas of Ipamorelin research discussion in peptide communities.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eLean-mass and muscle-support interest\u003c\/strong\u003e\u003cbr\u003eBecause Ipamorelin acts through the GH\/IGF-1 axis, researchers often discuss it in relation to lean tissue, muscle-protein signaling, recovery support, and physique-oriented study models. These areas should be framed as investigational research interests rather than guaranteed muscle-growth outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRecovery-oriented research\u003c\/strong\u003e\u003cbr\u003eIpamorelin is frequently discussed in peptide research communities for its possible relationship to recovery pathways, tissue maintenance, training adaptation, and restoration-related mechanisms. This interest is largely connected to broader GH\/IGF-1 signaling research and is often studied in the context of combination protocols with GHRH analogs.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSleep and nighttime protocol interest\u003c\/strong\u003e\u003cbr\u003eGrowth hormone secretion is naturally associated with sleep cycles, especially deeper sleep stages. Because Ipamorelin stimulates endogenous GH release, it is often discussed in nighttime research protocols involving pre-sleep timing, fasted administration models, overnight GH pulse interest, and sleep-associated recovery research. Pairing with a GHRH analog such as CJC-1295, Tesamorelin, or Sermorelin in nighttime protocols is a commonly referenced research model based on complementary receptor mechanisms.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSelective GH pulse stimulation\u003c\/strong\u003e\u003cbr\u003eUnlike direct growth hormone administration, Ipamorelin is researched for stimulating endogenous GH release through the GH secretagogue receptor pathway. At studied doses, researchers have noted relative selectivity for GH over other pituitary hormones, which is often cited as a distinguishing feature compared to earlier generation secretagogues. This makes it scientifically interesting for pulse-oriented hormone research and endocrine feedback models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMetabolic-marker investigation\u003c\/strong\u003e\u003cbr\u003eIpamorelin research may include interest in metabolic markers such as body composition parameters, lipid-related observations, and broader cardiometabolic profile investigations associated with GH\/IGF-1 axis activity. These outcomes can vary depending on study population and protocol design.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePhysique and performance-support research\u003c\/strong\u003e\u003cbr\u003eIn research-oriented discussions, Ipamorelin is often associated with lean-mass interest, body-composition research, recovery timing, and performance-support models. These should be described as research interests, not approved claims for athletic enhancement.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed or discussed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHormone-axis concerns\u003c\/strong\u003e\u003cbr\u003eBecause Ipamorelin affects GH and IGF-1 signaling, inappropriate use may raise concerns around elevated IGF-1, fluid retention, joint discomfort, glucose changes, numbness or tingling, and other hormone-related effects. These risks may be compounded when Ipamorelin is combined with GHRH analogs due to amplified GH output.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGlucose and insulin-sensitivity considerations\u003c\/strong\u003e\u003cbr\u003eGH-axis modulation may influence glucose metabolism in some settings. Research discussions around Ipamorelin should account for possible changes in blood sugar, insulin response, and metabolic risk factors, particularly in longer-duration or high-frequency protocols.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eUnknown long-term safety for unapproved use\u003c\/strong\u003e\u003cbr\u003eLong-term safety, dose-response, interaction risks, risk groups, and appropriate monitoring are not fully established for unapproved or research-grade use outside regulated clinical settings — particularly for combination protocols involving multiple peptides.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eIpamorelin is scientifically interesting for GH secretagogue receptor signaling, endogenous growth hormone release, GH\/IGF-1 axis research, body-composition studies, lean-mass interest, recovery-related models, and sleep-timing protocols. It is commonly researched in combination with GHRH analogs such as CJC-1295, Tesamorelin, and Sermorelin, based on the complementary receptor mechanisms these classes of peptides represent. While research around Ipamorelin is promising in specific contexts, broad claims around muscle growth, fat loss, sleep improvement, or anti-aging should not be overstated. Ipamorelin should only be studied under appropriate research conditions. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 5mg","offer_id":51941137744160,"sku":null,"price":1700.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 5mg","offer_id":51941137776928,"sku":null,"price":3400.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/ChatGPTImageMay25_2026_10_55_43PM_1.png?v=1783192910"},{"product_id":"bac-water","title":"Pharma-grade BAC Water (Reconstitution Solution | Bacteriostatic Water | Reconstitution \u0026 Lab Preparation)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp data-v-9492fc08=\"\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" class=\"additional-info-sections__item-description\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBacteriostatic Water for Injection, USP\u003c\/strong\u003e is a sterile, nonpyrogenic preparation of water for injection containing \u003cstrong\u003e0.9% (9 mg\/mL) benzyl alcohol\u003c\/strong\u003e added as a bacteriostatic preservative. This product is a solvent\/diluent only and contains no active therapeutic agents — it is not intended to be used for injection alone.\u003c\/p\u003e\n\u003ch3\u003eProduct characteristics\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSolvent\/diluent only\u003c\/strong\u003e\u003cbr\u003eContains no active therapeutic agents. Not intended to be used for injection alone.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePreservative\u003c\/strong\u003e\u003cbr\u003eContains 0.9% benzyl alcohol as a bacteriostatic preservative.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePharma grade\u003c\/strong\u003e\u003cbr\u003eManufactured to pharmaceutical-grade standards.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eUSP grade, sterile, and non-pyrogenic\u003c\/strong\u003e\u003cbr\u003eMeets USP monograph standards for sterility and non-pyrogenicity.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and considerations\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNot a standalone product\u003c\/strong\u003e\u003cbr\u003eThis diluent has no independent therapeutic or research effect on its own and is intended only for reconstitution or dilution purposes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eBenzyl alcohol content\u003c\/strong\u003e\u003cbr\u003eBecause it contains benzyl alcohol as a preservative, it is not appropriate for use in certain sensitive populations (e.g., neonates), consistent with standard USP labeling precautions for bacteriostatic water.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHandling and storage matter\u003c\/strong\u003e\u003cbr\u003eAs with any sterile diluent, proper aseptic technique, storage conditions, and shelf-life limits after first use should be observed to maintain sterility and product quality.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eBacteriostatic Water for Injection, USP is a sterile, USP-grade diluent intended solely for reconstitution and dilution purposes, with no independent therapeutic or research activity of its own. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 10 ml","offer_id":51941140300064,"sku":null,"price":100.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/ChatGPTImageJul5_2026_03_37_53AM.png?v=1783193890"}],"url":"https:\/\/sterilelabs.shop\/collections\/research-catalog.oembed","provider":"Sterile Labs","version":"1.0","type":"link"}